Table 1.
Characteristics of Surveyed Patients by Chlorhexidine Gluconate (CHG) and Mupirocin Adherence
| Characteristic | Fully Adherent with CHG (n=65), No. (%) | Not Fully Adherent with CHG (n=11), No. (%) | Total (n=76), No. (%) |
Fully Adherent with Mupirocin (n=9), No. (%) |
Not Fully Adherent with Mupirocin (n=8), No. (%) |
Total (n=17), No. (%) |
|---|---|---|---|---|---|---|
| Prior history of Staphylococcus infection among self or friend | 24 (36.9) | 4 (36.3) | 28 (36.8) | 3 (33.3) | 5 (62.5) | 8 (47.1) |
| Received product from | ||||||
| Hospital Pharmacy |
58 (89.2) | 7 (63.6) | 65 (85.5) | 9 (100) | 5 (62.5) | 14 (82.4) |
| 3 (4.6) | 2 (18.2) | 5 (6.6) | 0 | 2 (25.0) | 2 (11.8) | |
| Other | 4 (6.2) | 2 (18.2) | 6 (7.9) | 0 | 1 (12.5) | 1 (5.9) |
| Remembered receiving instructions for use | 63 (96.9) | 9 (81.8) | 72 (94.7) | 9 (100) | 8 (100) | 17 (100) |
| Reported ≥1 barrier to use | 2 (3.1) | 4 (36.4) | 6 (7.9) | 0 | 1 (12.5) | 1 (5.9) |
| Experienced side effect(s) | 6 (9.2) | 2 (18.2) | 8 (10.5) | 2 (22.2) | 3 (37.5) | 5 (29.4) |
| Age, median y (IQR) | 69 (60–72) |
70 (67–72) |
69 (60–72) |
68 (63–70) |
74 (69–77) |
70 (67–74) |
| More than high school degree | 40 (61.5) | 8 (72.7) | 48 (63.2) | 7 (77.8) | 5 (62.5) | 12 (71.6) |
| Annual income >$25,000 a | 50 (79.4) | 8 (72.7) | 58 (76.3) | 8 (88.9) | 3 (37.5) | 11 (64.7) |
| Willing to use again | 65 (100) | 10 (90.1) | 75 (98.6) | 9 (100) | 8 (100) | 17 (100) |
Note. IQR, interquartile range.
a
1 person preferred not to answer in mupirocin analysis; 3 people preferred not to answer in CHG analysis.